Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temodar with Stem Cell Transplant in Pediatric Solid Tumors
NCT00005952Phase 2Completed
- Sponsor
- Duke University
- Start
- Aug 2000
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in malignant glioma, central nervous system tumor, soft tissue sarcoma (STS), neuroblastoma, Wilms' tumor, sponsored by Duke University. Started Aug 2000; status: completed.
02
Drugs
temozolomide
03
Conditions
malignant gliomacentral nervous system tumorsoft tissue sarcoma (STS)neuroblastomaWilms' tumor
Beyond the preview
Go deeper on NCT00005952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005952.